Stramiello, Michael <br/><br/>
D1/5 receptor-mediated enhancement of LTP requires PKA, Src family kinases, and NR2B-containing NMDARs.  [electronic resource] 

 -  Neuropharmacology  Oct 2008 
 - 871-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2008.06.053  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine--pharmacology<br/>Animals<br/>Animals, Newborn<br/>Cyclic AMP-Dependent Protein Kinases--physiology<br/>Dopamine Agonists--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Electric Stimulation--methods<br/>Enzyme Inhibitors--pharmacology<br/>Hippocampus--drug effects<br/>In Vitro Techniques<br/>Long-Term Potentiation--drug effects<br/>Male<br/>Phenols--pharmacology<br/>Piperidines--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Dopamine D1--physiology<br/>Receptors, N-Methyl-D-Aspartate--antagonists & inhibitors<br/>src-Family Kinases--physiology